Juan Belmonte-Beitia

This study shows that EGFRwt/amp and EGFRvIII GBM models respond differently to radiotherapy and temozolomide, suggesting EGFR status could guide personalized treatment.

The paper develops a mathematical model of glioma growth incorporating tumor-associated macrophages to evaluate myeloid-targeted therapies and their combination with radiation.

This paper introduces a stochastic mesoscopic simulation framework to model tumor heterogeneity and evolutionary dynamics while maintaining low computational costs.